Dynavax Technologies Corp (DVAX)
12.46
+0.10
(+0.77%)
USD |
NASDAQ |
Nov 22, 13:20
Dynavax Technologies Gross Profit Margin (Quarterly): 83.77% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 83.77% |
| June 30, 2024 | 83.76% |
| March 31, 2024 | 78.41% |
| December 31, 2023 | 84.37% |
| September 30, 2023 | 80.97% |
| June 30, 2023 | 77.53% |
| March 31, 2023 | 68.65% |
| December 31, 2022 | 58.00% |
| September 30, 2022 | 63.43% |
| June 30, 2022 | 67.49% |
| March 31, 2022 | 64.94% |
| December 31, 2021 | 62.06% |
| September 30, 2021 | 44.50% |
| June 30, 2021 | 71.87% |
| Date | Value |
|---|---|
| March 31, 2021 | 70.45% |
| December 31, 2020 | 79.24% |
| September 30, 2020 | 69.95% |
| June 30, 2020 | 56.18% |
| March 31, 2020 | 57.40% |
| December 31, 2019 | 55.25% |
| September 30, 2019 | 41.86% |
| June 30, 2019 | 46.54% |
| March 31, 2019 | 29.45% |
| December 31, 2018 | 25.74% |
| September 30, 2018 | -430.5% |
| June 30, 2018 | -496.1% |
| March 31, 2018 | -1.49K% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
44.50%
Minimum
Sep 2021
84.37%
Maximum
Dec 2023
68.91%
Average
69.30%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Biogen Inc | 74.10% |
| Repligen Corp | 50.03% |
| West Pharmaceutical Services Inc | 35.44% |
| Janux Therapeutics Inc | -- |
| XOMA Royalty Corp | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 3.23% |
| Return on Assets | 2.03% |
| Return on Invested Capital | 2.39% |
| Profit Margin (Quarterly) | 21.82% |
| Operating Margin (Quarterly) | 12.50% |
| Return on Net Operating Assets | 10.81% |